Operating safe, therapeutic and clinically effective services is the responsibility of service providers to manage in accordance with best practice. NHS England\u2019s national service specifications for adult medium and low secure mental health services reinforce the importance of procedural, physical and relational security to address such matters. For high secure services, the Secretary of State for Health and Social Care issues specific Directions to providers regarding the way they must manage their security arrangements. These arrangements cover illicit substances.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2018-05-02", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-05-02T11:34:34.123Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-04-24", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mental Health Services: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to prevent illicit drugs being brought into secure mental health wards.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4677", "label" : {"_value" : "Biography information for Giles Watling"} } , "tablingMemberConstituency" : {"_value" : "Clacton"} , "tablingMemberPrinted" : [{"_value" : "Giles Watling"} ], "uin" : "137680"} , {"_about" : "http://data.parliament.uk/resources/435890", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/435890/answer", "answerText" : {"_value" : "
The conditions/therapy areas selected for the New Medicine Service (NMS) are those where community pharmacies are best able to demonstrate the value of the service and could provide the greatest benefit to patients. The conditions/therapy areas are currently asthma and chronic obstructive pulmonary disease, type 2 diabetes, antiplatelet/anticoagulant therapy and hypertension.<\/p>
As the commissioners of National Health Service pharmaceutical services it is for NHS England to consider, in light of the best available evidence, whether to negotiate changes to the NMS including whether the NMS should be offered to mental health patients.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2015-12-10", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-12-10T13:27:59.86Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-12-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mental Health Services: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, for what reasons the New Medicine Service is not available to mental health patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4036", "label" : {"_value" : "Biography information for Luciana Berger"} } , "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"} , "tablingMemberPrinted" : [{"_value" : "Luciana Berger"} ], "uin" : "19041"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }